Cargando…

Retrospective Evaluation of Lung Adenocarcinoma Patients Progressing on 1st Line Chemotherapy

Background and Objectives: Evaluation of data from electronic health care records could help in guiding towards more rational drug treatments. This single center study evaluated clinical characteristics that could be associated with disease progression. Methods: This was a real world data (RWD) stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vilhonen, Heikki, Kurki, Samu, Laitinen, Tarja, Hirsjärvi, Samuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915390/ https://www.ncbi.nlm.nih.gov/pubmed/31744064 http://dx.doi.org/10.3390/medicina55110743

Ejemplares similares

High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study
por: Talvitie, Eva-Maria, et al.
Publicado: (2020)

Clinical Characteristics and Disease Course of Fibrosing Interstitial Lung Disease Patients in a Real-World Setting
por: Kilpeläinen, Maritta, et al.
Publicado: (2023)

Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis
por: Talvitie, Eva-Maria, et al.
Publicado: (2022)

The burden of hip and knee osteoarthritis in Finnish occupational healthcare
por: Summanen, Milla, et al.
Publicado: (2021)

Use of electronic health record data mining for heart failure subtyping
por: Vuori, Matti A., et al.
Publicado: (2023)

Gender-specific change in leptin concentrations during long-term CPAP therapy
por: Aro, Miia, et al.
Publicado: (2019)

Erenumab Decreases Headache-Related Sick Leave Days and Health Care Visits: A Retrospective Real-World Study in Working Patients with Migraine
por: Autio, Henri, et al.
Publicado: (2021)

Is there a progression‐free survival benefit of first‐line crizotinib versus standard chemotherapy and second‐line crizotinib in ALK‐positive advanced lung adenocarcinoma? A retrospective study of Chinese patients
por: Cui, Shaohua, et al.
Publicado: (2016)

Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers
por: Palomäki, Antti, et al.
Publicado: (2021)

Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma
por: GÜRLER, Fatih, et al.
Publicado: (2022)

Burden of migraine in Finland: multimorbidity and phenotypic disease networks in occupational healthcare
por: Korolainen, Minna A., et al.
Publicado: (2020)

Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
por: Huusko, Jenni, et al.
Publicado: (2019)

Effect of metformin on residual cells after chemotherapy in a human lung adenocarcinoma cell line
por: KITAZONO, SATORU, et al.
Publicado: (2013)

Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines
por: Saar, Marika, et al.
Publicado: (2023)

Combined Checkpoint Inhibition and Chemotherapy: New Era of 1(st)-Line Treatment for Non-Small-Cell Lung Cancer
por: Wang, Chongkai, et al.
Publicado: (2019)

PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study
por: Huang, Zhe, et al.
Publicado: (2022)

Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review
por: Taimen, Kirsi, et al.
Publicado: (2020)

Microwave ablation combined with chemotherapy improved progression free survival of IV stage lung adenocarcinoma patients compared with chemotherapy alone
por: Li, Chunhai, et al.
Publicado: (2019)

The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013)

Real-world features associated with cancer-related venous thromboembolic events
por: Peippo, Maija Helena, et al.
Publicado: (2018)

The diagnostic cut-off points for components of sarcopenia in Finnish Caucasian women: A retrospective cross-sectional study
por: Sjöblom, Samu, et al.
Publicado: (2023)

Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
por: Lee, Kyoungmin, et al.
Publicado: (2020)

Physical inactivity in COPD and increased patient perception of dyspnea
por: Katajisto, Milla, et al.
Publicado: (2012)

AGTR1 Inhibits the Progression of Lung Adenocarcinoma
por: Xiong, Lecai, et al.
Publicado: (2021)

Evaluation of dynamic image progression of minimally invasive and preinvasive lung adenocarcinomas
por: Chen, Tianxiang, et al.
Publicado: (2021)

Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study
por: KNUUTILA, Jaakko S., et al.
Publicado: (2020)

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
por: He, Yayi, et al.
Publicado: (2020)

Serum Protein Pattern Could Predict the Therapeutic Effect of First-Line Pemetrexed/Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma
por: Shen, Hong, et al.
Publicado: (2015)

piR-hsa-211106 Inhibits the Progression of Lung Adenocarcinoma Through Pyruvate Carboxylase and Enhances Chemotherapy Sensitivity
por: Liu, Yongmei, et al.
Publicado: (2021)

The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy
por: Yang, Chih-Jen, et al.
Publicado: (2017)

Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2017)

Comorbidity of Dermal and Cardiovascular Disorders with Lichen Sclerosus: A Case-control Study
por: HIETA, Niina, et al.
Publicado: (2021)

Suppression of Lung Adenocarcinoma Progression by Nkx2-1
por: Winslow, Monte M., et al.
Publicado: (2011)

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis
por: Möhring, Christian, et al.
Publicado: (2021)

Estimating the effectiveness of pulmonary rehabilitation for COPD exacerbations: reduction of hospital inpatient days during the following year
por: Katajisto, Milla, et al.
Publicado: (2017)

Combination of apatinib mesylate and second-line chemotherapy for treating gastroesophageal junction adenocarcinoma
por: Lu, Bin, et al.
Publicado: (2019)

MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma
por: Sgarbura, Olivia, et al.
Publicado: (2019)

External Quality Assessment in the Evaluation of Laboratory Performance of Faecal Culture
por: Kiiskinen, Salla J, et al.
Publicado: (2017)

Motor vehicle accidents in CPAP-compliant obstructive sleep apnea patients—a long-term observational study
por: Myllylä, Minna, et al.
Publicado: (2020)

Documentation of the patient’s smoking status in common chronic diseases – analysis of medical narrative reports using the ULMFiT based text classification
por: Hirvonen, Eveliina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3cd6sbkdn7lif1e6u9tjifeoo9